Shorter-term Herceptin Sufficient? No Agreement Shorter-term Herceptin Sufficient? No Agreement

Different conclusions have been drawn from similar findings, perhaps as a result of subjective margins for equivalence in HER2+ breast cancer research.Medscape Medical News

Source: Medscape Hematology-Oncology Headlines - June 14, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news